Literature DB >> 9186815

Evaluation of bone turnover in postmenopause, vertebral fracture, and hip fracture using biochemical markers for bone formation and resorption.

M Takahashi1, K Kushida, H Hoshino, T Ohishi, T Inoue.   

Abstract

The purpose of this study is to evaluate bone turnover in postmenopausal status and established osteoporosis with vertebral fracture and hip fracture by assessing bone biochemical markers. Subjects were 50 healthy premenopausal subjects, 44 healthy postmenopausal subjects, 30 osteoporotic patients with vertebral fracture, and 31 osteoporotic patients with hip fracture. Alkaline phosphatase, osteocalcin, PICP, ICTP, NTx, free deoxypyridinoline, total pyridinoline and deoxypyridinoline were measured. In postmenopause, both Z-scores of bone formation markers and resorption markers were around 1-2. In osteoporosis, although Z-scores of bone formation markers were 0.4-2.8, resorption markers were 2.3-9.5. Moreover, Z-scores of resorption markers were higher in hip fracture than in vertebral fracture. These results indicate that bone formation and resorption increased and balanced in postmenopausal status. However, bone resorption increased more than bone formation and did not balance at all in osteoporosis. This imbalance is greater in hip fractures than in vertebral fractures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186815     DOI: 10.1007/BF03346887

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  Collagen cross-linking amino acids.

Authors:  D Eyre
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

2.  Increased bone resorption and decreased bone formation in Chinese patients with hip fracture.

Authors:  C K Cheung; N S Panesar; E Lau; J Woo; R Swaminathan
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

3.  Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion.

Authors:  P Garnero; E Gineyts; P Arbault; C Christiansen; P D Delmas
Journal:  J Bone Miner Res       Date:  1995-04       Impact factor: 6.741

4.  Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption.

Authors:  R Eastell; S P Robins; T Colwell; A M Assiri; B L Riggs; R G Russell
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

5.  Production and characterization of an antibody against the human bone GLA protein (BGP/osteocalcin) propeptide and its use in immunocytochemistry of bone cells.

Authors:  R Kasai; P Bianco; P G Robey; A J Kahn
Journal:  Bone Miner       Date:  1994-06

6.  A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine.

Authors:  D A Hanson; M A Weis; A M Bollen; S L Maslan; F R Singer; D R Eyre
Journal:  J Bone Miner Res       Date:  1992-11       Impact factor: 6.741

7.  Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.

Authors:  S P Robins; H Woitge; R Hesley; J Ju; S Seyedin; M J Seibel
Journal:  J Bone Miner Res       Date:  1994-10       Impact factor: 6.741

8.  Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients.

Authors:  T Chevalley; R Rizzoli; V Nydegger; D Slosman; C H Rapin; J P Michel; H Vasey; J P Bonjour
Journal:  Osteoporos Int       Date:  1994-09       Impact factor: 4.507

9.  Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase.

Authors:  A M Parfitt; L S Simon; A R Villanueva; S M Krane
Journal:  J Bone Miner Res       Date:  1987-10       Impact factor: 6.741

10.  Impairment of bone turnover in elderly women with hip fracture.

Authors:  K Akesson; P Vergnaud; E Gineyts; P D Delmas; K J Obrant
Journal:  Calcif Tissue Int       Date:  1993-09       Impact factor: 4.333

View more
  4 in total

1.  Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts.

Authors:  Akiyoshi Hoshino; Tadahiro Iimura; Satoshi Ueha; Sanshiro Hanada; Yutaka Maruoka; Mitsuori Mayahara; Keiko Suzuki; Toshio Imai; Masako Ito; Yoshinobu Manome; Masato Yasuhara; Takaaki Kirino; Akira Yamaguchi; Kouji Matsushima; Kenji Yamamoto
Journal:  J Biol Chem       Date:  2010-06-22       Impact factor: 5.157

2.  Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women's Health Initiative.

Authors:  Carolyn J Crandall; Sowmya Vasan; Andrea LaCroix; Meryl S LeBoff; Jane A Cauley; John A Robbins; Rebecca D Jackson; Douglas C Bauer
Journal:  J Bone Miner Res       Date:  2018-06-19       Impact factor: 6.741

3.  The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.

Authors:  Funda Tascioglu; Omer Colak; Onur Armagan; Ozkan Alatas; Cengiz Oner
Journal:  Rheumatol Int       Date:  2005-02-02       Impact factor: 2.631

4.  Analysis of Combined Indicators for Risk of Osteoporotic Hip Fracture in Elderly Women.

Authors:  Jin-Hui Zhao; Hui-Peng Shi; Da-Jun Jiang; Ling-Tian Wang; Sheng-Bao Chen; Wei-Tao Jia
Journal:  Orthop Surg       Date:  2021-05-04       Impact factor: 2.071

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.